QURE (STOCKS)
uniQure N.V.
$47.060000
+1.930000 (+4.28%)
Prev close: $45.130000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Matthew C. Kapusta
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,345.79M
- Employees
- 209
- P/E (TTM)
- -11.15
- P/B (TTM)
- 9.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
11
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.22 | $-0.84 | -0.3793 | -45.12% |
|
Mar 2026 (Q1)
|
$-0.85 | $-0.89 | +0.0436 | +4.88% |
|
Dec 2025 (Q4)
|
$-0.64 | $-0.97 | +0.3251 | +33.69% |
|
Sep 2025 (Q3)
|
$-1.38 | $-0.92 | -0.4624 | -50.39% |
Financial Statements
| Revenues | $18.67M |
| Benefits Costs and Expenses | $263.84M |
| Cost Of Revenue | $1.40M |
| Costs And Expenses | $212.18M |
| Gross Profit | $17.27M |
| Operating Expenses | $217.35M |
| Selling, General, and Administrative Expenses | $78.48M |
| Depreciation and Amortization | $14.47M |
| Research and Development | $132.29M |
| Operating Income/Loss | -$200.08M |
| Other Operating Income/Expenses | $3.33M |
| Income/Loss From Continuing Operations After Tax | -$252.21M |
| Income/Loss From Continuing Operations Before Tax | -$245.17M |
| Income Tax Expense/Benefit | $7.04M |
| Income Tax Expense/Benefit, Deferred | $3.01M |
| Net Income/Loss | -$252.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$252.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$252.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.03 |
| Diluted Earnings Per Share | -$4.03 |
| Basic Average Shares | 124,641,200 |
| Diluted Average Shares | 124,641,200 |
| Assets | $985.10M |
| Current Assets | $834.27M |
| Prepaid Expenses | $10.25M |
| Other Current Assets | $824.02M |
| Noncurrent Assets | $150.83M |
| Fixed Assets | $11.38M |
| Intangible Assets | $62.10M |
| Other Non-current Assets | $77.36M |
| Liabilities | $661.05M |
| Current Liabilities | $83.35M |
| Accounts Payable | $4.98M |
| Wages | $16.65M |
| Other Current Liabilities | $61.71M |
| Noncurrent Liabilities | $577.71M |
| Equity | $324.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $324.05M |
| Liabilities And Equity | $985.10M |
| Net Cash Flow From Operating Activities | -$160.79M |
| Net Cash Flow From Operating Activities, Continuing | -$160.79M |
| Net Cash Flow From Investing Activities | -$262.97M |
| Net Cash Flow From Investing Activities, Continuing | -$262.97M |
| Net Cash Flow From Financing Activities | $584.35M |
| Net Cash Flow From Financing Activities, Continuing | $584.35M |
| Exchange Gains/Losses | -$1.30M |
| Net Cash Flow | $159.29M |
| Net Cash Flow, Continuing | $160.59M |
| Comprehensive Income/Loss | -$251.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$251.56M |
| Other Comprehensive Income/Loss | -$79.88M |
| Other Comprehensive Income/Loss Attributable To Parent | $652.00K |